Asymmetric Catalysis in Organic Synthesis
Author Contributions
Funding
Conflicts of Interest
References
- Anonymous. Medicine: The Thalidomide Disaster. Time Mag. 10 August 1962. [Google Scholar]
- FDA’s Policy statement for the development of new stereoisomeric drugs. Chirality 1992, 4, 338–340. [CrossRef]
- Branch, S. International regulation of chiral drugs, in Chiral Separation Techniques. In A Practical Approach, 2nd ed.; Subramanian, G., Ed.; Wiley-VCH: Weinheim, Germany, 2001; pp. 319–342. [Google Scholar]
- Rauws, A.G.; Groen, K. Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States. Chirality 1994, 6, 72–75. [Google Scholar] [CrossRef] [PubMed]
- Investigation of Chiral Active Substances—3CC29a. Quality Guidelines, Standards and Guidelines, Theraputic Drug Adminstration (TGA) 2002. Available online: https://www.tga.gov.au/quality-guidelines (accessed on 22 January 2019).
- Van Arnum, P. Single-enantiomer drugs drive advances in asymmetric synthesis (Cover story). Pharm. Technol. 2006, 30, 58–66. [Google Scholar]
- Bolm, C.; Beller, M. Transition Metals for Organic Synthesis: Building Blocks and Fine Chemicals. In Second Revised and Enlarged Edition; Wiley-VCH: Weinheim, Germany, 2008. [Google Scholar]
- Bates, R. Organic Synthesis Using Transition Metals; John Wiley & Sons: Chickester, UK, 2012. [Google Scholar]
- Oliveira, V.; Cardoso, M.; Forezi, L. Organocatalysis: A Brief Overview on Its Evolution and Applications. Catalysts 2018, 8, 605. [Google Scholar] [CrossRef]
- Berkessel, A.; Gröger, H. Asymmetric Organocatalysis: From Biomimetic Concepts to Applications in Asymmetric Synthesis; John Wiley & Sons: Weinheim, Germany, 2006. [Google Scholar]
- Crawley, M.L.; Trost, B.M. Applications of Transition Metal Catalysis in Drug Discovery and Development: An Industrial Perspective; John Wiley & Sons: Hoboken, NJ, USA, 2012. [Google Scholar]
- Li, H.; Luo, M.; Tao, G.; Qin, S. Theoretical Calculations on the Mechanism of Enantioselective Copper (I)-Catalyzed Addition of Enynes to Ketones. Catalysts 2018, 8, 359. [Google Scholar] [CrossRef]
- Adly, F.G.; Bollard, H.; Gardiner, M.G.; Ghanem, A. Chiral dirhodium (II) carboxylates: New insights into the effect of ligand stereo-purity on catalyst structure and enantioselectivity. Catalysts 2018, 8, 268. [Google Scholar] [CrossRef]
- Li, J.; Zhou, B.; Jiang, Y.; Liu, X. Synthesis of New C2-Symmetric Six-Membered NHCs and Their Application for the Asymmetric Diethylzinc Addition of Arylaldehydes. Catalysts 2018, 8, 46. [Google Scholar] [CrossRef]
- Rafiński, Z. NHC-Catalyzed Organocatalytic Asymmetric Approach to 2, 2-Disubstituted Benzofuran-3 (2H)-ones Containing Fully Substituted Quaternary Stereogenic Center. Catalysts 2019, 9, 192. [Google Scholar] [CrossRef]
- Adly, F.G. On the structure of chiral dirhodium (II) carboxylate catalysts: Stereoselectivity relevance and insights. Catalysts 2017, 7, 347. [Google Scholar] [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Adly, F.G.; Ghanem, A. Asymmetric Catalysis in Organic Synthesis. Catalysts 2019, 9, 775. https://doi.org/10.3390/catal9090775
Adly FG, Ghanem A. Asymmetric Catalysis in Organic Synthesis. Catalysts. 2019; 9(9):775. https://doi.org/10.3390/catal9090775
Chicago/Turabian StyleAdly, Frady G., and Ashraf Ghanem. 2019. "Asymmetric Catalysis in Organic Synthesis" Catalysts 9, no. 9: 775. https://doi.org/10.3390/catal9090775